Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III Parallel, Double-blind, Non-inferiority Study With Active Control, to Evaluate the Immunogenicity and Safety of a Booster Immunization Scheme With a Single Intramuscular Dose of the Recombinant Vaccine Against SARS-CoV-2

NCT05710783 is registered in ClinicalTrials.gov with Laboratorio Avi-Mex, S.A. de C.V. as lead sponsor.

NCT NCT05710783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05710783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III Parallel, Double-blind, Non-inferiority Study With Active Control, to Evaluate the Immunogenicity and Safety of a Booster Immunization Scheme With a Single Intramuscular Dose of the Recombinant Vaccine Against SARS-CoV-2
Lead sponsor
Laboratorio Avi-Mex, S.A. de C.V.
Phase
Phase 2/3
Overall status
Completed
Start date
November 9, 2022
Completion date
September 10, 2023
Enrollment
4,065 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection